Epi One

Back in 1999, Nvidia sold shares at its IPO at $12 a piece. If you'd have purchased 100 shares at that time, your $1200 investment would now be worth $5.79 million. That's what can happen when a transformative technology is launched. There are now just 7 days to take advantage of our crowdfunding campaign and be a part of something truly special in the field of cancer diagnostics...

Our StartEngine crowdfunding campaign is now the offering with the most investment on the entire platform in the last few days. But there are now only a few days left for you to get involved. If you'd like to know more about being a part of our mission to save millions of lives, head to https://lnkd.in/eYrJiFKJ. But don't delay!

Quick reminder: tomorrow sees our final live online session before our StartEngine crowdfunding round closes on 4th December. In this session our CEO Michael Marquardt and our chief scientific officer and co-founder Dr Sophia Fang are going to reveal exactly how our technology works to detect cancer early, accurately and cost-effectively, and they'll be looking at our development timeline and milestones. Don't miss out! Register at https://lnkd.in/ewRKNmiG

In this clip from the Test. Optimize. Scale. podcast, our CEO Michael Marquardt explains how Epi One is built on the merging of the medical and computational technology fields. He also talks about the unique perspective and knowledge that our founder Dr Sophia Fang brings to the table, and why Epi One is unique on the field of cancer diagnostics. You can find the show wherever you normally listen to podcasts.

We are thrilled to announce that the scientific genius behind Epi One, Dr Sophia Fang, will be joining our CEO, Michael Marquardt, for a very special webinar on November 26th. Together they'll be covering exactly how our technology works to detect cancer early, accurately and cost-effectively, and they'll be looking at our development timeline and milestones. This is a fantastic opportunity to hear from one of the leading scientific minds in the cancer detection space ahead of the closing of our crowdfunding round on December 4th. Register at https://lnkd.in/eqjw3YJh

As our crowdfunding round starts to draw to a close, a few words from Michael Marquardt, our CEO...

What if we could detect cancer before symptoms appear, potentially saving millions of lives? At Epi One, we're not just imagining this future - we're building it. Our approach could significantly impact healthcare. There is a critical need for early cancer detection and so we're addressing one of its most pressing issues. Our DNA-based biomarker method is also innovative. It enables us to focus on the trifecta of earlier AND more accurate AND more affordable cancer detection. And our team is led by world-class scientists, who bring leading edge expertise to this challenge. But the most exciting part for you is that YOU can be part of this potential healthcare transformation. Join our crowdfunding campaign before it's too late at https://lnkd.in/eYrJiFKJ

Having the right environment to nurture innovation and growth is crucial for us at Epi One. And SUNY Downstate's Biotech Incubator offers us access to cutting-edge laboratory facilities, ensuring that we can conduct our groundbreaking research in cancer detection without the limitations often faced by early-stage biotech companies. Having our lab space here gives us access to the vast resources of SUNY Downstate Medical Center, an ecosystem that provides Epi One with a wealth of knowledge, expertise, and resources that would be challenging and costly to acquire independently. The incubator environment fosters networking and collaboration, and this setup also allows us to allocate more resources to research and development rather than facility management. In short, securing lab space at the Downstate Biotechnology Incubator represents a significant strategic advantage. Our crowdfunding campaign with StartEngine ends in just two weeks' time. Don't miss out on being a part of this revolution!

Epi One CEO Michael Marquardt was recently invited on to the Test. Optimize. Scale. podcast to talk about what we're doing here at Epi One. In this clip he discusses why he is so passionate and driven to ensure that we succeed in our mission. You can find the show wherever you normally listen to podcasts.

We are thrilled to share with you that our equity crowdfunding campaign has now reached the?$1.5 million?mark. This moves us closer to our goal of advancing early cancer detection technology and, in total, we have now raised more than?$4.6 million. With only 19 days?remaining in our offering, this is an opportunity to join over 300 investors who believe in our mission to support early, accurate cancer diagnosis and treatment. Join them now via the link below ??